Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities-Reference-Cited by-同舟云学术

Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities

Published:2010-02-10 Issue:9 Volume:49 Page:2008-2017
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Liu Min¹,Dobson Brittany¹,Glicksman Marcie A.¹,Yue Zhenyu²,Stein Ross L.³

Affiliation:

1. Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, 65 Landsdowne Street, Fourth Floor, Cambridge, Massachusetts 02139

2. Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029-6500

3. Discovery Research, Sirtris Pharmaceuticals, Cambridge, Massachusetts 02139

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi901851y

Reference32 articles.

1. MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE

2. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease

3. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

4. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*

5. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism;2024-08-28

2. Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism;2024-04-09

3. ARL15, a GTPase implicated in rheumatoid arthritis, potentially repositions its truncated N-terminus as a function of guanine nucleotide binding;International Journal of Biological Macromolecules;2024-01

4. DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson’s disease;Expert Opinion on Investigational Drugs;2023-09-02

5. Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism;2023-07-31